SML0332
依地芬
≥95% (HPLC), apoptosis inducer, powder
别名:
1-十八烷基-2-甲基甘油-3-磷酸胆碱, 4-羟基-7-甲氧基-N,N,N-三甲基-3,5,9-三氧四-4-磷庚烷-1-氧化铵-4-氧化物, ALP, ET 18-OCH3, ET-18-OMe, NSC 324368, NSC 343649, Ro 14-5243, 外消旋1-O-十八烷基-2-O-甲基甘油-3-磷酸胆碱
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C27H58NO6P
化学文摘社编号:
分子量:
523.73
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
产品名称
依地芬, ≥95% (HPLC)
SMILES string
CCCCCCCCCCCCCCCCCCOCC(COP([O-])(=O)OCC[N+](C)(C)C)OC
InChI
1S/C27H58NO6P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-23-32-25-27(31-5)26-34-35(29,30)33-24-22-28(2,3)4/h27H,6-26H2,1-5H3
InChI key
MHFRGQHAERHWKZ-UHFFFAOYSA-N
assay
≥95% (HPLC)
form
powder
color
white to beige
solubility
H2O: 15 mg/mL (clear solution)
shipped in
wet ice
storage temp.
−20°C
Quality Level
相关类别
Application
依地福新已用于治疗人肺癌 A549 细胞，并研究其对 Tuftelin 1（TUFT1）表达的影响。它还用于评估 MCF-7/M 细胞的细胞生长。
Biochem/physiol Actions
依地福新是一种合成烷基-赖氨磷脂，具有抗肿瘤活性。
依地福新是一种合成烷基-赖氨磷脂，具有抗肿瘤活性。该化合物诱导多种癌细胞的凋亡。乙二胺嘧啶在细胞膜中积累，在细胞膜中改变脂质成分并诱导脂质筏和 Fas/CD95 死亡受体的共簇。
Features and Benefits
这种化合物是激酶磷酸酶生物学研究的特色产品。点击此处发现更多特色激酶磷酸酶生物产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。
General description
依地福新具有抗炎、抗自身免疫、抗寄生虫和抗病毒的特性。它通过细胞收缩和细胞膜扰乱来刺激红细胞衰亡。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Monica Rapino et al.
Nanomaterials (Basel, Switzerland), 9(7) (2019-06-30)
Dental pulp stem cells (DPSCs) represent a population of stem cells which could be useful in oral and maxillofacial reconstruction. They are part of the periendothelial niche, where their crosstalk with endothelial cells is crucial in the cellular response to
The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
Scherbakov AM, et al.
IUBMB Life, 68(4), 281-292 (2016)
Joo Hee Choi et al.
Colloids and surfaces. B, Biointerfaces, 181, 879-889 (2019-08-07)
In this study, a double network hydrogel of a natural polysaccharide gellan gum (GG) hydrogel and a synthetic hydrogel poloxamer-heparin (PoH) hydrogel (PoH/GG DNH) is introduced to complement disadvantages of each hydrogel and improve the microenvironment for cell delivery. The
Xiaolin Xu et al.
Experimental animals, 68(3), 371-380 (2019-04-05)
Ketogenic diet (KD) has been used in epilepsy for decades, but previous studies found it may cause severe bone loss. Every-other-day ketogenic diet (EODKD), the combination of KD with intermittent fasting, showed better potential for seizure control recently, while its
TUFT1 interacts with RABGAP1 and regulates mTORC1 signaling.
Kawasaki N, et al.
Cell discovery, 4(1), 1-1 (2018)
商品
Discover Bioactive Small Molecules for Kinase Phosphatase Biology
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持